We conducted an ELISA experiment to measure the changes in PD-L1 expression levels in tumor tissues of the Hepal-6 liver cancer model before the start of treatment (12 days after in situ cell inoculation) and after the end of treatment (27 days after in situ cell inoculation) (Figure S5). This evidence concerns the gene CD274 and liver cancer.